BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 10842327)

  • 1. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
    Liu Y; McKalip A; Herman B
    J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis.
    Chen QM; Merrett JB; Dilley T; Purdom S
    Oncogene; 2002 Aug; 21(34):5313-24. PubMed ID: 12149652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis.
    Stöppler H; Stöppler MC; Johnson E; Simbulan-Rosenthal CM; Smulson ME; Iyer S; Rosenthal DS; Schlegel R
    Oncogene; 1998 Sep; 17(10):1207-14. PubMed ID: 9771963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
    Aguilar-Lemarroy A; Gariglio P; Whitaker NJ; Eichhorst ST; zur Hausen H; Krammer PH; Rösl F
    Oncogene; 2002 Jan; 21(2):165-75. PubMed ID: 11803460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes.
    Liu X; Han S; Baluda MA; Park NH
    Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.
    Iglesias M; Yen K; Gaiotti D; Hildesheim A; Stoler MH; Woodworth CD
    Oncogene; 1998 Sep; 17(10):1195-205. PubMed ID: 9771962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression.
    Du J; Chen GG; Vlantis AC; Chan PK; Tsang RK; van Hasselt CA
    Cancer Lett; 2004 Mar; 205(1):81-8. PubMed ID: 15036664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7.
    Kamradt MC; Mohideen N; Krueger E; Walter S; Vaughan AT
    Br J Cancer; 2000 May; 82(10):1709-16. PubMed ID: 10817508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plant lignan, 3'-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells.
    Allen KL; Tschantz DR; Awad KS; Lynch WP; DeLucia AL
    Mol Carcinog; 2007 Jul; 46(7):564-75. PubMed ID: 17393435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
    Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors.
    Toussaint-Smith E; Donner DB; Roman A
    Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
    Kang YH; Lee KA; Ryu CJ; Lee HG; Lim JS; Park SN; Paik SG; Yoon DY
    Cancer Lett; 2006 Jun; 237(1):33-44. PubMed ID: 16019139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
    Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA
    Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
    Wu GS; Ding Z
    Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways executing the "trophic sentinel" response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation.
    Eichten A; Rud DS; Grace M; Piboonniyom SO; Zacny V; Münger K
    Virology; 2004 Feb; 319(1):81-93. PubMed ID: 14967490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.